InvestorsHub Logo

leifsmith

06/25/16 10:41 AM

#122576 RE: arvitar #122571

he supply of unlicensed medicinal products (“specials”) - UK

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf

May be ordered by hospital pharmacists, and I see nothing in this description that would prevent NNVC from charging a "market" price (no government regulation of pricing). Therefore, for a herpes treatment or a flu treatment, there is prospect of profit.